Bismuth subsalicylate during pregnancy and breast feeing

Bismuth subsalicylate during pregnancy and lactation, Bismuth subsalicylate category by FDA, its use during pregnancy and lactation its teratogenic effects are described.

Small amount of drug excrete into breast milk, if required low dose should be prescribed.

Bismuth subsalicylate  during pregnancy and lactation
Pregnancy	Category  Not assigned
	Bismuth subsalicylate crosses the placenta, Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans. drug should not be used during pregnancy unless the benefit outweighs the risk to the fetus.
Breast feeding	Bismuth subsalicylate excretes into breastmilk in small quantities, effect on nursing infant unknown, use with caution, not recommended